Free Trial

Progyny (PGNY) Competitors

Progyny logo
$19.49 -0.01 (-0.05%)
Closing price 04:00 PM Eastern
Extended Trading
$19.35 -0.14 (-0.72%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PGNY vs. RDNT, BTSG, SHC, OPCH, WGS, PRVA, HTFL, VCYT, CON, and SGRY

Should you be buying Progyny stock or one of its competitors? The main competitors of Progyny include RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Option Care Health (OPCH), GeneDx (WGS), Privia Health Group (PRVA), Heartflow (HTFL), Veracyte (VCYT), Concentra Group Holdings Parent (CON), and Surgery Partners (SGRY). These companies are all part of the "healthcare" industry.

Progyny vs. Its Competitors

Progyny (NASDAQ:PGNY) and RadNet (NASDAQ:RDNT) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, valuation, institutional ownership, dividends, risk and analyst recommendations.

Progyny currently has a consensus target price of $25.44, suggesting a potential upside of 30.55%. RadNet has a consensus target price of $76.80, suggesting a potential downside of 7.92%. Given Progyny's higher probable upside, analysts plainly believe Progyny is more favorable than RadNet.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Progyny
0 Sell rating(s)
4 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.70
RadNet
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
3 Strong Buy rating(s)
3.13

Progyny has a beta of 1.34, meaning that its stock price is 34% more volatile than the S&P 500. Comparatively, RadNet has a beta of 1.59, meaning that its stock price is 59% more volatile than the S&P 500.

In the previous week, Progyny had 3 more articles in the media than RadNet. MarketBeat recorded 12 mentions for Progyny and 9 mentions for RadNet. RadNet's average media sentiment score of 1.14 beat Progyny's score of 0.45 indicating that RadNet is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Progyny
4 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
RadNet
6 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Progyny has higher earnings, but lower revenue than RadNet. RadNet is trading at a lower price-to-earnings ratio than Progyny, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Progyny$1.17B1.44$54.34M$0.5933.03
RadNet$1.83B3.51$2.79M-$0.20-417.05

94.9% of Progyny shares are held by institutional investors. Comparatively, 77.9% of RadNet shares are held by institutional investors. 9.4% of Progyny shares are held by company insiders. Comparatively, 5.6% of RadNet shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Progyny has a net margin of 4.28% compared to RadNet's net margin of -0.78%. Progyny's return on equity of 10.69% beat RadNet's return on equity.

Company Net Margins Return on Equity Return on Assets
Progyny4.28% 10.69% 7.12%
RadNet -0.78%2.41%0.82%

Summary

Progyny beats RadNet on 11 of the 17 factors compared between the two stocks.

Get Progyny News Delivered to You Automatically

Sign up to receive the latest news and ratings for PGNY and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PGNY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PGNY vs. The Competition

MetricProgynyMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$1.68B$8.46B$6.23B$10.68B
Dividend YieldN/A2.12%5.71%4.82%
P/E Ratio33.0379.4730.0629.84
Price / Sales1.4442.77587.23131.17
Price / Cash56.5121.6037.0161.44
Price / Book3.937.8412.046.60
Net Income$54.34M$250.93M$3.32B$276.82M
7 Day Performance0.78%3.32%1.79%2.07%
1 Month Performance-10.18%-1.10%6.28%2.62%
1 Year Performance25.34%17.30%61.13%32.86%

Progyny Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PGNY
Progyny
3.5196 of 5 stars
$19.49
-0.1%
$25.44
+30.6%
+23.0%$1.68B$1.17B33.03310News Coverage
RDNT
RadNet
3.4539 of 5 stars
$71.72
+1.6%
$76.80
+7.1%
+22.6%$5.43B$1.83B-358.5811,021Positive News
BTSG
BrightSpring Health Services
2.4502 of 5 stars
$29.48
+3.9%
$30.50
+3.5%
+112.3%$5.02B$11.27B38.3235,000News Coverage
Earnings Report
Analyst Forecast
Insider Trade
SHC
Sotera Health
2.581 of 5 stars
$15.67
+2.1%
$17.20
+9.8%
+9.0%$4.36B$1.10B24.363,000Positive News
OPCH
Option Care Health
4.6898 of 5 stars
$26.67
-0.1%
$35.11
+31.7%
-6.7%$4.33B$5.00B18.558,088News Coverage
Positive News
Upcoming Earnings
WGS
GeneDx
2.941 of 5 stars
$120.87
-0.7%
$104.13
-13.9%
+123.0%$3.50B$305.45M80.081,200Upcoming Earnings
Analyst Forecast
PRVA
Privia Health Group
2.8852 of 5 stars
$24.14
+0.2%
$28.91
+19.8%
+47.8%$2.96B$1.74B218.911,140
HTFL
Heartflow
N/A$33.22
-0.7%
$36.60
+10.2%
N/A$2.79BN/A0.00699News Coverage
VCYT
Veracyte
3.805 of 5 stars
$34.09
-2.0%
$40.90
+20.0%
+9.8%$2.74B$445.76M103.31790Analyst Forecast
CON
Concentra Group Holdings Parent
2.5755 of 5 stars
$20.17
-0.7%
$27.75
+37.6%
-4.1%$2.60B$1.90B16.9511,250News Coverage
Analyst Forecast
SGRY
Surgery Partners
3.783 of 5 stars
$19.79
+0.3%
$32.00
+61.7%
-30.4%$2.53B$3.11B31.8415,000News Coverage
Positive News

Related Companies and Tools


This page (NASDAQ:PGNY) was last updated on 10/24/2025 by MarketBeat.com Staff
From Our Partners